Sanofi and Zentiva - Top 10 deals of 2008

FierceBiotech's top 10 deals of 2008 report featuring Sanofi-Aventis' acquisition of Zentiva.Who: Sanofi-Aventis
With: Zentiva
What: $2.6B buyout

Summary: After making several bids for Czech generic drugmaker Zentiva, Sanofi-Aventis finally struck gold with a 1,150 Czech crowns-per-share bid of $2.6 billion. Sanofi is one of several Big Pharmas on this list to pay big bucks to beef up its generic capability, which will likely play an important roll in the drug industry in the years ahead.

Sanofi and Zentiva - Top 10 deals of 2008

Suggested Articles

Horizon Therapeutics is expanding its U.S. footprint to the Bay Area—the company unveiled a new R&D and manufacturing site in South San Francisco.

Azeria Therapeutics has raised £32 million ($41 million) to take its estrogen receptor positive breast cancer program into the clinic.

Biogen’s Al Sandrock has given a bullish assessment of Alzheimer’s disease drug aducanumab. The head of R&D at Biogen thinks the drug works, despite i